The Novavax vaccine showed an efficacy rate of about 90 per cent in trials. Getty
The Novavax vaccine showed an efficacy rate of about 90 per cent in trials. Getty
Europe's vaccine sceptics offered Novavax doses to overcome fears
Protein-based product is lined up for health workers and the unvaccinated after social media backlash
